Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-803 in Acute HIV Infection
NCT04505501Phase 2Active, not recruiting
- Sponsor
- Thai Red Cross AIDS and Infectious Diseases Research Centre
- Start
- Mar 2021
- Primary completion
- Jun 2025
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of nogapendekin alfa inbakicept in human immunodeficiency virus infection (HIV), sponsored by Thai Red Cross AIDS and Infectious Diseases Research Centre. Started Mar 2021; status: active, not recruiting.
02
Drugs
nogapendekin alfa inbakicept
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04505501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505501.